EvoNexus Portfolio Company Odin Diagnostics Signs CRADA with the Naval Health Research Center
EvoNexus portfolio company Odin Diagnostics has signed a three-year Cooperative Research and Development Agreement (CRADA) with the Naval Health Research Center (NHRC). The agreement brings Odin Diagnostics together with NHRC […]
EvoNexus Portfolio Company CARI Health Wins ISAM’s 2026 Golden Brain Innovation Award
EvoNexus portfolio company CARI Health has won the Golden Brain Innovation Award at the International Society of Addiction Medicine (ISAM) Global Addiction Therapeutics Innovation Day (GATID) 2026. The award was […]
EvoNexus Portfolio Company Finally Quiet Named 2026 OCBJ Innovator of the Year
EvoNexus portfolio company Finally Quiet was named the 2026 Innovator of the Year by the Orange County Business Journal, the second straight year an EvoNexus Irvine company has won the award.
No Needle, No Prescription: EvoNexus Graduate Biolinq Earns FDA Clearance for Over-the-Counter Biolinq Shine
We’re thrilled to celebrate another major regulatory milestone for Biolinq, an EvoNexus graduate. On September 24, 2026, the San Diego company announced that the U.S. Food and Drug Administration has […]
Corramedical, an EvoNexus Portfolio Company, Announces Formation of Scientific Advisory Board
Corramedical, an EvoNexus Portfolio Company, Announces Formation of Scientific Advisory Board To Accelerate Company’s Mission to Make Precision Medicine Available to More Patients; Thought Leaders in Pathology, Oncology, Radiology, and […]
EvoNexus 2025 Portfolio Venture Funding on Track for Record-Breaking Year
EvoNexus 2025 Portfolio Venture Funding on Track for Record-Breaking Year “When Vice Admiral Walter Davis and I founded EvoNexus in 2010, our initial goal was first to see if the […]
EvoNexus Graduate, Biolinq Announces Close of $100M Series C Financing to Advance Its Biowearable Platform for Metabolic Health
EvoNexus Graduate, Biolinq Announces Close of $100M Series C Financing to Advance Its Biowearable Platform for Metabolic Health The Series C funding supports Biolinq’s transition from development stage to commercial […]